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Abstract 
Background: Impaired skin barrier is an important etiological factor 
in atopic dermatitis (AD). The structural protein filaggrin (FLG) plays a 
major role in maintenance of the competent skin barrier and its 
deficiency is associated with enhanced susceptibility to mechanical 
injury. Here we examined biomechanical characteristics of the 
corneocytes in children with AD and healthy controls. 
Methods: We recruited 20 children with AD and 7 healthy children. 
They were genotyped for filaggrin gene (FLG) loss-of-function 
mutations. Stratum corneum was collected from clinically unaffected 
skin by adhesive tapes. Cell stiffness (apparent elastic modulus, Ea) 
was determined by atomic force microscopy and filaggrin degradation 
products (NMF) by liquid chromatography. Skin barrier function was 
assessed through trans-epidermal water loss (TEWL) and disease 
severity by the SCORing Atopic Dermatitis (SCORAD) tool. 
Results:  Corneocytes collected from AD patients showed a decreased 
elastic modulus which was strongly correlated with NMF and TEWL, 
but not with SCORAD. As compared with healthy controls, AD patients 
had reduced TEWL and NMF levels regardless of FLG mutations. NMF 
was strongly correlated with TEWL. 
Conclusion: Our findings demonstrate that AD patients have 
decreased corneocyte stiffness which correlates with reduced levels of 
filaggrin degradation products, NMF and skin barrier function. Altered 
mechanical properties of the corneocytes likely contribute to the loss 
of mechanical integrity of the SC and to reduced skin barrier function 
in AD.
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Introduction
Atopic dermatitis (AD) is a common inflammatory skin disease, 
with a lifetime prevalence up to 20% (Drislane & Irvine, 2020; 
Weidinger et al., 2018). Impaired skin permeability barrier, 
which is largely provided by the stratum corneum (SC), is an 
important etiological factor in AD (Elias & Schmuth, 2009; 
Kezic et al., 2014). SC, the outermost skin layer is comprised 
of terminally differentiated, anucleated keratinocytes, called 
corneocytes, embedded in a layered extracellular lipid matrix. 
Corneocytes are delimited by cornified envelopes (CE) - insoluble 
10 nm thick structures composed of highly crosslinked proteins 
covalently bound to a 5 nm thick monolayer of ceramides replac-
ing cell membranes of viable keratinocytes. They are joined 
together by modified desmosomes immobilized by cross-linking 
to the CE and attached to the keratin cytoskeleton filling the 
cell interior (Elias, 2008).
Intrinsic or acquired deficiency of an epidermal protein 
filaggrin is regarded as a major contributor to the compromised 
skin barrier function in AD (McAleer & Irvine, 2013; 
O’Regan et al., 2009). Filaggrin has multiple roles in mainte-
nance of the mechanical integrity of the SC barrier. It aligns 
keratin filaments within the corneocytes and contributes to 
the composition and structure of CE, thus likely affecting the 
mechanical properties of the corneocytes. Indirectly, filaggrin 
influences the SC mechanical integrity through its degradation 
products, which contribute to a pool of hygroscopic 
molecules collectively called natural moisturizing factors (NMF). 
NMF regulate SC hydration, crucial for the plasticity of the 
skin, its pH and activity of enzymes involved in key homeo-
static processes in the SC including lipid synthesis, maturation 
of CE and desquamation (Guneri et al., 2019; Rawlings, 2014). 
Therefore, deficiency of filaggrin will likely affect mechanical 
stability of the SC and its resistance to cracking and chapping, 
common hallmarks of AD skin.
Recently, we have demonstrated in mouse models that filag-
grin and/or NMF deficiency lead to altered topography of 
the corneocyte surface and to its decreased elastic modulus 
(Thyssen et al., 2019). In the present study, we investigated 
whether mechanical properties of the corneocytes are affected in 
AD developed by humans and how they correlate with FLG gen-
otype, NMF levels and permeability barrier function measured 
by trans-epidermal water loss (TEWL) in clinically non-affected 
skin of the patients.
Methods
Study population
Children with AD (n = 20) were recruited in a dedicated AD 
clinic in Children’s Health Ireland at Crumlin, Dublin between 
Jan 2013 and July 2013. Individuals were identified from a 
cohort of children attending this clinic, sequential patients who 
attended the clinic and who met the inclusion/exclusion crite-
ria were invited to attend. Severity of disease was determined 
by a Scoring Atopic Dermatitis (SCORAD) score. All patients 
were treatment naive, apart from the use of emollients and 
hydrocortisone 1% cream or ointment. All patients were asked 
not to use any topical agents for 24 h prior to assessment. As 
controls, seven children were recruited when attending for elec-
tive procedures under general anesthesia. Inclusion criteria for 
the control group were not having AD, any history suggestive 
of AD or any other inflammatory skin disease. As this was an 
explorative study with no prior data to guide us as to effect 
size, we were not able to calculate power estimates prior to 
the study commencement. In order to be certain that we fully 
understood the FLG status of participants we only included chil-
dren with 4 Irish grandparents. Children who had previously used 
topical corticosteroids stronger than 1% hydrocortisone or who 
had used topical tacrolimus were excluded. There were no other 
exclusion criteria. The study was conducted in accordance with the 
Declaration of Helsinki and was approved by the research ethics 
committee of Our Lady’s Children’s Hospital, Dublin. Written 
informed consent was obtained from all patients’ parents.
Stratum corneum trans-epidermal water loss measurement
TEWL measurements were performed under standardized con-
ditions (room temperature of 22–25 °C and humidity levels of 
30–35%). Patients were acclimatized for a minimum of 10 min. 
prior to measurement. TEWL was assessed on the clinically 
unaffected skin on the volar forearm using the Tewameter 300 
(Courage + Khazaka electronic GmbH, Cologne, Germany).
Sampling of the stratum corneum by tape stripping
The SC was collected using the previously described method 
(McAleer et al., 2018; McAleer et al., 2019) using circular 
adhesive tape strips (3·8 cm2, D-Squame; Monaderm, Monaco) 
and a D-Squame pressure instrument D500 (CuDerm, Dallas, 
TX, U.S.A.). The adhesive tape was placed on the skin, 2 cm 
away from the lesion, and pressed for 10 seconds with a pres-
sure of 225 g cm2 using a D-Squame pressure instrument. 
Sequentially, eight consecutive tape strips were sampled from 
the same site and immediately stored at −80 °C. For the NMF 
analysis the 4th tape was used, and for AFM analysis the 7th tape.
Atomic force microscopy (AFM)
The detailed description of the AFM approach employed for 
measuring corneocyte stiffness at various cell depths has been 
recently published (Milani et al., 2018). The experimental set-
ting is schematized in Figure 1. Briefly, tape strips were thawed, 
and let equilibrate for 30 minutes in the controlled atmosphere of 
the AFM facility (relative humidity = 45%; temperature = 24°C) 
and a small piece of each sample was stuck onto glass slides. 
AFM indentation experiments were carried out with a Catalyst 
Bioscope (Bruker Nano Surface, Santa Barbara, CA, USA) that was 
mounted on an optical macroscope (MacroFluo, Leica, Germany) 
equipped with a x10 objective. A Nanoscope V controller and 
Nanoscope software versions 8.15 were utilized. All quantita-
tive measurements were performed using standard pyramidal 
tips (MPP-21100, Bruker AFM probes, Inc.). The tip radius 
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Figure 1. Stiffness tomography study of the mechanical properties (resistance) of a corneocyte (Level L7). The method consists in 
extracting the elastic modulus at different indentation depths, in intervals of 5 nm, as presented on the force curve (F; in nN, to the right). 
A representative fitting curve is drawn for three different segments. The surface zone of two 5 nm intervals covers here the lipid envelope. 
Follow the deeper parts composed of the next two 5 nm intervals representing the cornified envelope and the keratin-rich cell interior 
recorded at 20 and 50 nm, respectively. A tomographic representation of the obtained stiffness measurements is presented (middle of the 
panel). The red colour corresponds to high rigidity and the green to a softer material (see the colour scale at the bottom). The heterogeneous 
mechanical properties can be observed. The lipid envelope is relatively flexible when compared with the corneocyte interior composed of the 
keratin -rich matrix. The cornified envelope shows an intermediate stiffness. A transmission electron microscopy image of the intermediate 
part of SC demonstrates the relative narrowness of the lipid and cornified envelopes visualized at the corneocyte periphery, next to the 
corneodesmosomes (arrows), when compared with the whole cell breadth. (From Milani et al., 2018) , copyright held by M Haftek. SC: stratum 
corneum.
given by the manufacturer was 8–12 nm. Each AFM experi-
ment consisted in acquiring a topographic image of the centre of 
a cell (10 × 10 µm) and a square matrix of force curves 
(21–126 readings, mean readings =100; at 1µm steps in the 
imaged area). For each tape-strip, the study was conducted on 
9–10 individual cells (except in case of two AD patients with 
one FLG mutation and one AD patient wild type for FLG muta-
tions, 5 and 4 cells were used, respectively) using PeakForce 
QNM AFM mode at a low frequency (0.5 kHz) with the maxi-
mum applied force of 150 nN. Force curves analysis permitted 
extraction of the quantitative data of the elastic modulus by 
applying the Hertz–Sneddon model for an indentation ranging 
from 0 to 50 nm.
FLG genotyping
All patients were screened for the nine most common filag-
grin mutations found in the Irish population (R501X, 2282del4, 
R2447X, S1010X, G1139X, R3419X, 3702delG, Y209X and 
S3247X), by either restriction digest or direct Sanger sequenc-
ing, Full details including primers sequences and PCR cycling 
conditions are listed in Table 1. PCR amplification reactions 
were performed on a Biometra T3000 Thermocycler (Göttingen, 
Germany). 
Determination of filaggrin breakdown products in the 
stratum corneum
Natural moisturizing factor (NMF) component analysis (his-
tidine, pyrrolidone carboxylic acid, trans- and cis-urocanic 
acid) and proteins was performed on the fourth consecutive 
strip according to the method previously described (McAleer 
et al., 2019). NMF components were extracted with 500 µL 
25% (w/w) ammonia solution (Merck Milllipore, The 
Netherlands, cat. Nr 105432), reconstituted in 500 µL water after 
evaporating ammonia and analysed by UV high-performance 
liquid chromatography (HPLC). The column used was a 
250 × 3 mm reversed-phase Synergi 4 mm Polar-RP 80A 
column (Phenomenex, Torrance, CA, USA; catalogue number 
OOG-4336-Y0) at flow rate of 0.4 mL/min, delivered by 
Jasco PU-980 HPLC pump (Jasco, Tokyo, Japan). Isocratic 
elution was performed with a mobile phase, consisting of 
4.3 mM hydrochloric acid (Merck Millipore, The Netherlands, 
catalogue number 6871317), 0.1 mM sodium octane-1-sulfonate 
(Merck Millipore, catalogue number 1.1830070025), and 2% 
acetonitrile (Biosolve, The Netherlands, catalogue number 
001207802bs). To compensate for variable amount of stratum 
corneum on the tape, NMF concentrations were normalized for 
protein concentration. Proteins were determined with a Pierce 
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Table 1. Screening for FLG mutations: PCR, Restriction digest and/or sequencing conditions.
Mutation Primers Cycling 
conditions
Restriction digest or sequencing strategy
501X F 5’ CAC GGA AAG GCT GGG CTG A 3’ 
R 5’ ACC TGA GTG TCC AGA CCT ATT 3’
94°C 5min (x1) 
94°C 30sec 
57°C 30sec 
72°C 1min (x35) 
72°C 5min (x1)
R501X was screened by restriction digest of a 
312bp product 
R501X introduces a NlaIII restriction site. To 
determine presence of the R501X mutation digest 
PCR product with NlaIII: 
Run digests on a 3% (w/v) agarose gel. 
Wildtype allele cuts to give fragments of 182bp, 
109bp and 21bp. 
Mutant allele cuts to give fragments of 127bp, 
109bp, 55bp and 21bp.
2282del4 F 5’ AAT AGG TCT GGA CAC TCA GGT 3’ 
R 5’ GGG AGG ACT CAG ACT GTT T 3’
94°C 5min (x1) 
94°C 30sec 
57°C 30sec 
72°C 1min (x35) 
72°C 5min (x1
2282del4was screened by restriction digest of a 
811bp product 
2282del4 introduces a DraIII restriction site. 
To determine presence of the 2282del4 mutation 
digest PCR product with DraIII: 
Run digests on a 2% (w/v) agarose gel. 
Wildtype allele 811bp. 
Mutant allele cuts to give fragments of 671bp and 
140bp
R2447X F 5’ CCA CAC GTG GCC GGT CAG CA 3’ 
R 5’ GTC CTG ACC CTC TTG GGA CGT 3’
94°C 5min (x1) 
94°C 30sec 
64°C 30sec 
72°C 1min (x35) 
72°C 5min (x1
R2447X was screened by restriction digest of a 
185bp product. 
R2447X introduces a NlaIII restriction site. 
To determine presence of the R2447X mutation 
digest PCR product with NlaIII: 
Run digests on a 10% TBE polyacrylamide gel. 
Wildtype allele cuts to give fragments of 95bp, 
69bp and 21bp. 
Mutant allele cuts to give fragments of 69bp, 55bp, 
40bp and 21bp.
S1040X F 5’ CCAGACAATCAGGAACTCC 3’ 
R 5’ ATGAGTGCTCACCTGGTAGAT 3’
94°C 3 min (x1) 
94°C 30sec 
62°C 30sec 
72°C 1 min (x34) 
72°C for 5 min 
S1040X was screened by restriction digest of a 
375bp PCR product. 
S1040X creates a BtsI site, digestion with this 
enzyme yields fragments of 251bp and 124bp 
(mutant allele) whereas the wildtype allele is uncut 
(375bp).
G1139X F 5’ CCAGACAATCAGGAACTCC 3 
R 5’ ATGAGTGCTCACCTGGTAGAT 3
94°C 3 min 
94°C 30sec 
62°C 30sec 
72°C 1 min (x34) 
72°C 5 min
G1139X was screened by restriction digest of a 
653bp PCR product. 
G1139X abolishes a TspRI site, digestion with this 
enzyme yields fragments of 393bp, 157bp, 51bp, 
31bp, 15bp and 6bp (wildtype allele) whereas the 
mutant allele generates fragments of 550bp, 51bp, 
31bp, 15bp and 6bp
R3419X F 5’GCCCATGGGCGGACCAGGA 3’ 
R 5’GCTTCATGGTGATGCGACCA 3’
94°C 3 min 
94°C 30sec 
61°C 30sec 
72°C 1 min(x34) 
72°C 5 min
R3419X was screened by restriction digest of a 
332bp PCR product 
R3419X creates a NlaIII site and digestion with 
this enzyme yields fragments of 307bp, 14bp, 7bp 
and 4bp (wildtype allele) whereas the mutant allele 
produces fragments of 252bp, 55bp, 14bp, 7bp 
and 4bp
3702delG F 5’ GCA AGC AGA CAA ACT CGT AAG 3’ 
R 5’CAG ACA ACC TCT CGG AGT CG 3’’
94°C 3 min 
94°C 30sec 
62°C 30sec 
72°C 1 min (x34) 
72°C 5 min
3702delG was screened by direct sequencing of 
a ~217bp PCR product. Use reverse primer as the 
sequencing primer. 
Sequenced on Applied Biosystems (Waltham, 
Massachusetts, USA) 3100 DNA sequencer
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Mutation Primers Cycling 
conditions
Restriction digest or sequencing strategy
Y2092X F 5’ CA CAG TCA GTG TCA GCA CAG 3’ 
R 5’ GGC TAA CAC TGG ATC CCC GGG 3’
94°C 3 min 
94°C 30sec 
62°C 30sec 
72°C 1 min (x34) 
72°C 5 min
Y2092X was screened by direct sequencing 
of a 574bp PCR product. Use forward primer a 
sequencing primer 
Sequenced on Applied Biosystems (Waltham, 
Massachusetts, USA) 3100 DNA sequencer
S3247X F 5’ GTA ATG AGG AAC AAT CAG GAG ACA 3’ 
R 5’ CTG GGG TGT CTG GAG CCG TGC 3
94°C 5min 
94°C 30sec 
64°C 30sec 
72°C 45sec (x34) 
72°C 5min
S3247X was screened by direct amplification of a 
268bp product. Use forward primer a sequencing 
primer 
Sequenced on Applied Biosystems (Waltham, 
Massachusetts, USA) 3100 DNA sequencer
Micro BCA protein assay kit (Thermo Fischer Scientific, 
Rockford, IL, USA; catalogue  number 687131723235.
Statistics
Calculations were performed by using Prism 7 software 
(GraphPad, San Diego, CA). Difference in TEWL, Ea and NMF 
between AD patients and healthy controls was tested by 2-tailed 
Student’ or Welch’s t-test in the case of non-equal variance. 
Differences in Ea and NMF between AD patients with and 
without FLG mutations and the healthy controls wild-type for 
FLG mutations were tested by 2-tailed Student’ and Welch’s 
t-test, respectively. Spearman’s rank correlation coefficient was 
used to test the strength of the relationship between NMF, Ea, 
SCORAD and TEWL. Distribution of data was tested by 
Shapiro-Wilks normality test. P-value < 0.05 was considered 
significant.
Results
Clinical data
Summary of demographic details of the investigated population 
is given in Table 2 (individual values are available as underly-
ing data (Irvine, 2020)). Most of AD children had moderate to 
severe disease (SCORAD > 25) (Kunz et al., 1997). At least 
one FLG mutation was found to be carried in 15 children, while 
in the healthy controls there were two heterozygous carri-
ers of FLG mutations. The skin barrier function, as assessed by 
TEWL on non-involved skin of the volar forearm, was signifi-
cantly lower in AD patients when compared to healthy controls 
(P<0.01).
Cell topography
Corneocytes obtained with the seventh tape strip from 
the non-involved forearm skin were examined and their 
lower surface was recorded using AFM topography mode. 
Representative AFM images regarding disease status and FLG 
genotype are shown in Figure 2 (individual images are provided 
as underlying data (Irvine, 2020)). Clear-cut differences in cell 
surface morphology characterised by presence of numerous 
micro-protrusions were observed in AD patients, compared 
to healthy subjects. The slight variation between images 
recorded within the healthy and AD groups was also noted, 
according to the FLG genotype, but these differences were not 
quantified in the present study. Of note, cells from subjects that 
are heterozygous carriers of FLG-loss of function (LOF) muta-
tions but did not develop AD, remained free of the surface 
alteration observed in AD.
Statistical comparisons between AD and healthy groups 
with regard to the barrier function, corneocyte stiffness and 
NMF contents
As shown in Figure 3A, AD patients had significantly lower 
elastic moduli (Ea) of corneocytes as compared to healthy 
controls. A similar pattern has been observed for NMF 
(Figure 3B). The values of Ea in AD patients were significantly 
lower as compared to the healthy controls, irrespective of the 
presence of FLG mutations (P<0.01 and P<0.0001, for the 
non-carriers and FLG mutations carriers, respectively). The 
same pattern has been observed for NMF (P<0.05 and P<0.01, 
for the non-carriers and FLG mutations carriers, respectively). 
Table 2. Demographic details of the study participants.
Patients (n = 20) Controls (n = 7)
Gendera 12 males, 6 females 5 males, 2 females
Age (months) (mean, range) 16.8 (3-92) 8.5 (3-12)
SCORAD (Average, range) 47.2 (9.7-70.5) n.a.
TEWL (Average, range)b,* 24.7 (9.4-43.1) 9.6 (4.0-13.1)
FLG status: 
    Wild-type 
    Heterozygous LOF mutation 
    Homozygous/compound 
heterozygous LOF mutations
 
5 
10 
5
 
5 
2 
0
afor two AD patients no gender was noted
bfor one healthy control no TEWL was noted
*Difference between patients and healthy controls, P<0.01; n.a.: not 
applicable
TEWL: Transepidermal Water Loss
SCORAD: (SCORing Atopic Dermatitis) tool
LOF: Loss-of-function
FLG: filaggrin gene
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Figure 2. Representative examples of morphological modifications of corneocyte surface in AD compared to healthy controls. Cell 
surface topography of cells harvested with the 7th consecutive tape strip in healthy subjects and AD patients presenting various FLG 
genotypes. Corneocytes from AD patients show numerous micro-protrusions uniformly distributed at the cell surface.
Figure 3. Elastic modulus (Ea) (A); natural moisturizing factors (NMF) (B) and transepidermal water loss (TEWL) (C) in healthy controls and 
patients. In the figures A and B, FLG genotype is given for each subject using different symbols, as indicated in panel A. Differences in Ea, 
NMF and TEWL between AD patients and controls were tested by a 2-way Student t-test. **P<0.01, ****P<0.0001.
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Figure  4.  Relationships  between  investigated  parameters.  A) Regression analysis between Young elastic modulus (Ea) and natural 
moisturizing factors (NMF). R2: determination coefficient. B) Heat-map showing relationships between NMF, Ea, SCORAD and TEWL and 
corresponding levels of significance (P: Spearman correlation coefficient). ***P<0.001; ****P<0.0001.
AD patients had reduced skin barrier function as assessed 
by TEWL (Figure 3C).
The values of apparent elastic moduli (Ea) were strongly and 
positively correlated with NMF and negatively with TEWL 
(Figure 4). In contrast, there was no significant association of 
Ea with disease severity as assessed by SCORAD. The val-
ues of TEWL were negatively correlated with NMF, indicating 
higher water permeability of SC presenting lower water hold-
ing capacity. However, there was no significant association 
between TEWL and SCORAD (Figure 4).
Discussion
According to the “brick and mortar” concept of the SC 
permeability barrier, cellular elements sealed by intercellular lip-
ids constitute a largely hydrophobic “wall” responsible for the 
protective functions of the outermost epidermal layer (Elias, 
1983). In AD, these structural elements are or become deficient, 
leading to an increased transepidermal penetration of environ-
mental antigens and development of immune inflammatory 
responses (Elias et al., 2008; Elias & Schmuth, 2009).
In a substantial proportion of AD patients, especially those of 
the North European origin, loss-of-function mutations in the 
filaggrin gene (FLG) have been incriminated in the pathogenesis 
of AD (Drislane & Irvine, 2020; O’Regan et al., 2009). 
Homozygous occurrence of such mutations additionally leads 
to hyperkeratosis, presenting clinically in the form of Ich-
thyosis vulgaris (Thyssen et al., 2013), what may be an attempt 
to compensate for the leaky barrier. The exact mechanism 
through which filaggrin deficiency leads to insufficient barrier 
function is not yet fully understood, but there are several lines 
of evidence demonstrating that not only filaggrin but also its 
degradation products play a role (Thyssen & Kezic, 2014). 
Filaggrin participates in compaction of the keratins within 
corneocytes, and is the principal source of NMF which is 
indispensable for correct SC hydration and plasticity, and 
becomes integrated into the cornified envelopes – the struc-
tural scaffolds for organisation of the intercellular lipid layers. 
We hypothesised that physical proprieties of corneocytes 
in AD patients would be altered contributing to impaired 
skin barrier. Indeed, in the present study, we showed that 
AD patients had significantly softer corneocytes compared to 
their healthy counterparts of similar age-range and of the 
same geographic origin, and that their elastic modulus was 
inversely associated with TEWL, a marker for disordered skin 
barrier function. Interestingly, a lower elastic modulus was 
also found in non-involved skin of AD patients irrespective 
of the presence of FLG mutations. The role of inflamma-
tion with paracrine diffusion of pro-inflammatory chemokines, 
cytokines and histamine should be considered as a poten-
tial source of systemic subclinical effects on non-involved 
skin of AD (Danso et al., 2017; Elias et al., 2008; Gschwandtner 
et al., 2013; Sawada et al., 2012). Several studies convinc-
ingly showed that FLG expression is downregulated by 
local Th2 cytokine milieu in AD (Howell et al., 2007; Kezic 
et al., 2011). A recent report incriminated one of the catalytic 
enzymes from the NMF production cascade in regulation of 
the inflammatory response. Specifically, deficient expression 
of keratinocyte bleomycin hydrolase resulted, in addition to 
the decreased degradation of filaggrin monomers into free 
amino acids, in an increased release of pro-inflammatory che-
mokines that are upregulated in skin of AD patients com-
pared to healthy individuals (Riise et al., 2019). Because FLG 
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mutations remain the principal determinant of filaggrin expres-
sion and its downstream processing cascade, we quantified the 
levels of filaggrin breakdown products in the tape-stripped cor-
neocytes. In agreement with previous studies, we found that, in 
comparison with healthy controls, AD patients had reduced NMF 
levels even in absence of FLG mutations. Furthermore, NMF 
levels were strongly associated with a reduced elastic modu-
lus, indicating that filaggrin breakdown products contribute to 
the corneocyte mechanical strength. Consistently, in our recent 
study carried out in mouse models of filaggrin and/or NMF 
processing, we showed that NMF was strongly correlated with 
cell stiffness and affected corneocyte topography (Thyssen 
et al., 2019). Of note, in the present study there was no inverse 
correlation of SCORAD with the corneocyte elastic modu-
lus. Also this fits very well with data obtained in mouse models 
of filaggrin and/or NMF deficiency, where softer SC cells and 
increased TEWL occurred in the absence of macroscopically 
observable inflammation (Thyssen et al., 2019). This together 
strongly suggests that inflammation as such is not required 
for abrogation of the mechanical properties of the corneocytes.
The AFM images of the corneocyte surface in clinically non-
involved skin of AD patients showed presence of numerous 
protrusions, which is in agreement with our previous inves-
tigation (Riethmuller et al., 2015). Notably, in that latter 
study the protrusions showed a dense distribution, co-existing 
with surface expression of corneodesmosin, suggesting that 
weakness of the cornified envelope due to imperfect corneocyte 
maturation was the reason for altered corneocyte surface texture 
in AD. Cornified cell envelopes undergo progressive matura-
tion within the SC that results in increase of the cell stiffness 
(Michel et al., 1988; Milani et al., 2018). This process appears 
to rely largely on hydration-dependent activities of transglu-
taminase 1 and 12R-lipoxygenase (Guneri et al., 2019). It is, 
therefore, not surprising that in AD, characterized by low 
NMF content and, consequently, reduced hydration, expres-
sion of mRNA and the corresponding proteins composing CE is 
decreased (Trzeciak et al., 2017).
Various AFM studies of human SC have been previously per-
formed to examine differences in corneocyte morphology and/or 
stiffness, mostly according to the anatomic localization of 
the sampled area and to the cell position within the SC depth 
(Fredonnet et al., 2014; Milani et al., 2018). Based on our pre-
vious work and the present study, it may be concluded that the 
apparent elastic modulus (Ea) represents a valid measure of the 
SC maturity, with all the functional consequences related to 
a given status. In line with this, the present report confirms that 
defective permeability barrier function (increased TEWL) in AD 
correlates with both low NMF values and relative immaturity 
of corneocytes.
The strength of the present study is homogeneity of the samples 
regarding SC depth, body location and of the age and ethnic 
origin of the study population, factors known to influence 
skin barrier (Bensaci et al., 2015; Fluhr et al., 2014; Liu 
et al., 2018; McAleer et al., 2018). The main limitation of 
the study was the small number of healthy subjects with 
FLG mutations which constitute an interesting subgroup for 
further studies. The number of intragenic copies within the 
FLG gene is known to influence susceptibility to the disease 
(Brown et al., 2012). This factor could be one more element 
helpful in dissecting the studied population into subgroups with 
different clinical outcomes. Furthermore, our findings do not 
exclude a possible impact of alterations of the corneocyte surface 
topography, resulting from CE immaturity, on the organisa-
tion of extracellular lipid bi-layers – the principal element of 
waterproofness of the SC barrier (Elias, 2008; van Smeden & 
Bouwstra, 2016). Finally, while we were careful to choose clini-
cally non-involved sites, with no obvious inflammation, for 
sampling we cannot exclude the possibility that subclinical 
inflammation could influence corneocyte elasticity.
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This manuscript by Haftek et al. describes the changes in nano-mechanical properties found in 
cornified keratinocytes of children with atopic dermatitis. The authors study the skin of twenty AD 
patients and seven healthy children. Using adhesive tapes, cell stiffness and filaggrin degradation 
products named natural moisturizing factors were analyzed. In addition, transepidermal water 
loss (TEWL) was measured and disease severity was assessed using the SCORAD index. This data 
was complemented with FLG genotyping for the nine most common FLG mutations. The authors 
report that cellular stiffness is significantly lower in AD patients compared to healthy volunteers, 
which is in line with lowered NMF levels and heightened TEWL values. The manuscript is well 
written and easy to read. The data is convincingly presented and investigated parameters (such as 
cell stiffness, NMF component concentration, and epidermal water loss) nicely correlate with each 
other. 
  
Main remarks:
The authors state that they tape-stripped the volunteers and measured NMF content on the 
4th strip, and cell topography on the 7th strip for each and every volunteer, regardless of the 
skin type (healthy vs. atopic dermatitis). The authors do not present data or explain their 
choice to use the 4th and 7th strip. Healthy skin and AD skin (even non-involved skin) can be 
distinct based on stratum corneum thickness, adhesiveness, water loss, water content, 
protein degradation product quantity, plasticity, and more. This could directly influence the 
efficiency of the tape-stripping procedure, and at which stratum corneum layers the 
investigated parameters can be most effectively measured. Although the method of tape-
stripping is widely accepted and used, and non-lesional skin was studied, the authors 
should explain that the chosen strips are indeed comparable between patients vs controls. 
 
1. 
The authors sampled non-lesional skin, at 2 cm distance from the lesional sites. It could well 
be that the skin at this 2 cm distance is affected by the inflammation at the lesional sites (e.g 
via diffusion of inflammatory molecules or migration of inflammatory cells). Since the non-
lesional skin sites were not investigated by tissue morphology (which is understandable 
given the pediatric population), the authors conclusions that “inflammation as such is not 
2. 
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required for abrogation of the mechanical properties of the corneocytes” may therefore be 
overstated. Could it be that more distant uninvolved skin (e.g. at a different body location) 
would render a different study outcome? In line with this comment, were any local disease 
severity parameters assessed (e.g. SUM score), besides the overall SCORAD, to better define 
the non-lesional skin?   
Minor remarks:
Methods section, “Atomic force microscopy (AFM)”: The third sentence repeats itself partly. 
 
○
Methods section, “FLG genotyping”: ‘&209xA’ should be ‘Y2092X’○
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Department of Dermatology, Venereology and Allergy, Medical University of Innsbruck, Innsbruck, 
Austria 
This manuscript describes biophysical properties of corneocytes collected by D-squame tape strips 
from patients with atopic dermatitis (AD) as compared to those harvested from healthy control 
subjects. The research question is interesting, the study design is clear. Some of the 
measurements (NMF, AFM) were reported in prior independent investigations in skin samples, i.e. 
citations Riethmuller et al. 2015; and Thyssen et al. 2019. In the present manuscript, the authors 
confirm structural corneocyte alterations in AD and they provide additional evidence about 
decreased corneocyte stiffness calculated as elastic modulus. Decreased corneocyte stiffness 
positively correlates with levels of natural moisturizing factor (NMF) and negatively correlates with 
transepidermal water loss (TEWL). 
  
Specific details as to how the authors can address any criticisms and improve the work: 
  
Table 1: May be moved to supplements. 
  
Table 2: Available information on gender should be listed not only as number of males – the 
footnote may be overlooked, this may be misleading. 
  
Table 2: The information on age suggests that groups are not comparable (upper limit of range 
and average age are very different). Thus, the authors should avoid stressing similar age range in 
the discussion on pages 8 and 9. The mean should be shown rather than the average (or both). 
  
Methods: Please add a more succinct description of how Ea is determined by stiffness 
tomography. 
  
Figure 1: The transmission electron microscopy image shown in this figure depicts multiple 
corneodesmosomes. The figure legend states the narrowness of lipid cornified envelopes next to 
corneodesmosomes. To what degree does Ea depend on corneodesmosome density? 
  
Figure 1: It should be checked, if reproducing this figure (previously published in Milani et al. in 
2018, figure 2) is in concordance with journal policies. 
  
Figure 3: Can the TEWL data in figures 3C be shown to include genotype information (as in figures 
3A and B)? 
  
Results/ Discussion: The increased presence of micro-protrusions should be discussed in more 
detail. What is the structural and biochemical basis for micro-protrusions? Since the authors state 
that decreased cornified envelope stiffness in AD may be linked to imperfect corneocyte 
maturation, data on corneocyte maturation, related enzymes (e.g. transglutaminase-1, 12R-
lipoxygenase), and presence of mediators of inflammation (e.g. cytokines) would be helpful, if 
available (not required).
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Is the study design appropriate and is the work technically sound?
Yes
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If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
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Are the conclusions drawn adequately supported by the results?
Yes
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I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard, however I have 
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Comments on this article
Version 1
Author Response 13 Jul 2020
Alan Irvine, Children's Health Ireland at Crumlin, Dublin, Ireland 
Reviewer 1 
  
This manuscript describes biophysical properties of corneocytes collected by D-squame tape strips 
from patients with atopic dermatitis (AD) as compared to those harvested from healthy control 
subjects. The research question is interesting, the study design is clear. Some of the measurements 
(NMF, AFM) were reported in prior independent investigations in skin samples, i.e. citations 
Riethmuller et al. 2015; and Thyssen et al. 2019. In the present manuscript, the authors confirm 
structural corneocyte alterations in AD and they provide additional evidence about decreased 
corneocyte stiffness calculated as elastic modulus. Decreased corneocyte stiffness positively 
correlates with levels of natural moisturizing factor (NMF) and negatively correlates with 
transepidermal water loss (TEWL). 
  
Specific details as to how the authors can address any criticisms and improve the work: 
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Table 1: May be moved to supplements. 
  
The paper was formatted as is by request of the Wellcome Open Access editorial team 
  
Table 2: Available information on gender should be listed not only as number of males – the 
footnote may be overlooked, this may be misleading. 
  
We have added the female data to Table 2 (Table 2) 
  
Table 2: The information on age suggests that groups are not comparable (upper limit of range 
and average age are very different). Thus, the authors should avoid stressing similar age range in 
the discussion on pages 8 and 9. The mean should be shown rather than the average (or both). 
  
We now list mean age. We only reference age once in the discussion, where we say the 
groups are of ‘similar’ age which we feel is accurate and reasonable. 
  
Methods: Please add a more succinct description of how Ea is determined by stiffness tomography. 
  
Here follows a more succinct description: 
  
The methodological approach of AFM stiffness tomography of human SC corneocytes has 
been validated and fully described in the previous publication (Milani et al., 2018). In short, 
the Young modulus (Ea) is a measurement of relative elasticity/rigidity of the substrate 
probed with a tip of an AFM apparatus. Force curves reflecting the substrate’s physical 
interactions with the tip are recorded and analysed using previously defined algorithms. 
  
As there are no restrictions on paper length we have not shortened the existing description 
which we believe makes it easier to replicate these experiments. 
  
Figure 1: The transmission electron microscopy image shown in this figure depicts multiple 
corneodesmosomes. The figure legend states the narrowness of lipid cornified envelopes next to 
corneodesmosomes. To what degree does Ea depend on corneodesmosome density? 
  
The Figure’s legend indicates the presence of lipid envelopes, best visualized in 
corneodesmosome proximity, due to the contrast provided by the extra and intra cellular 
elements of the junctions. In fact, the thickness of the envelopes does not vary depending on 
the corneodesmosome distribution. Because the quantitative data on cell rigidity (Ea) are 
result of measurements performed at 100 spots distributed over the 100 µm² array placed in 
the centre of each and every cell studied, they reflect the overall stiffness, whatever the 
desmosome frequency in a given sample. The fact that the study was performed on cells 
from the 7th strip, obtained from the deeper part of the SC, permitted us to avoid a possible 
influence of the process of corneodesmosome degradation and desquamation. 
 
Figure 1: It should be checked, if reproducing this figure (previously published in Milani et al. in 
2018, figure 2) is in concordance with journal policies.  
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As stated in the paper-the copyright belongs to M Haftek. 
  
Figure 3: Can the TEWL data in figures 3C be shown to include genotype information (as in figures 
3A and B)? 
  
We have now provided this revised figure as requested 
 
Results/ Discussion: The increased presence of micro-protrusions should be discussed in more 
detail. What is the structural and biochemical basis for micro-protrusions?  
  
We discussed the nature of protrusions in our previous papers which are both cited in this 
manuscript (Thyssen et al, 2019 and Riethmuller et al 2015).   
  
Since the authors state that decreased cornified envelope stiffness in AD may be linked to 
imperfect corneocyte maturation, data on corneocyte maturation, related enzymes (e.g. 
transglutaminase-1, 12R-lipoxygenase), and presence of mediators of inflammation (e.g. cytokines) 
would be helpful, if available (not required). 
  
  
We appreciate these comments and fully agree but unfortunately do not have these 
additional data points available
Is the work clearly and accurately presented and does it cite the current literature?•
Yes
Is the study design appropriate and is the work technically sound?•
Yes
Are sufficient details of methods and analysis provided to allow replication by others?•
Partly
If applicable, is the statistical analysis and its interpretation appropriate?•
Yes
Are all the source data underlying the results available to ensure full reproducibility?•
Yes
Are the conclusions drawn adequately supported by the results?•
Yes 
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Reviewer 2 
  
This manuscript by Haftek et al. describes the changes in nano-mechanical properties found in 
cornified keratinocytes of children with atopic dermatitis. The authors study the skin of twenty AD 
patients and seven healthy children. Using adhesive tapes, cell stiffness and filaggrin degradation 
products named natural moisturizing factors were analyzed. In addition, transepidermal water loss 
(TEWL) was measured and disease severity was assessed using the SCORAD index. This data was 
complemented with FLG genotyping for the nine most common FLG mutations. The authors report 
that cellular stiffness is significantly lower in AD patients compared to healthy volunteers, which is 
in line with lowered NMF levels and heightened TEWL values. The manuscript is well written and 
easy to read. The data is convincingly presented and investigated parameters (such as cell stiffness, 
NMF component concentration, and epidermal water loss) nicely correlate with each other. 
  
Main remarks:
The authors state that they tape-stripped the volunteers and measured NMF content on the 
4th strip, and cell topography on the 7th strip for each and every volunteer, regardless of the 
skin type (healthy vs. atopic dermatitis). The authors do not present data or explain their 
choice to use the 4th and 7th strip. Healthy skin and AD skin (even non-involved skin) can be 
distinct based on stratum corneum thickness, adhesiveness, water loss, water content, 
protein degradation product quantity, plasticity, and more. This could directly influence the 
efficiency of the tape-stripping procedure, and at which stratum corneum layers the 
investigated parameters can be most effectively measured. Although the method of tape-
stripping is widely accepted and used, and non-lesional skin was studied, the authors should 
explain that the chosen strips are indeed comparable between patients vs controls.
1. 
We appreciate these comments. In this and in prior stratum corneum studies we performed 
multiple analyses on limited material from infant skin. For that reason, we had to limit our 
studies to prespecified strips. For NMF we normalized for total protein to standardize our 
analyses between cases and controls. 
For NMF we found in our previous study in small children, that there was no variation in NMF 
levels with SC depth after 48 h of age (McAleer 2018).  
To ensure that NMF measurement in different age groups and sites was not affected by 
varying SC thickness, NMF profiling was performed on consecutive tape strips in 13 
individuals. NMF was assessed in the second, sixth and eighth tape stripping in participants 
from < 48 h to 3 months of age at the cheek and elbow sites. We found good reproducibility 
of NMF readings between these strip depths. 
For morphological studies we have previously shown no depth dependency on surface 
topology when quantitatively measured by DTI (Reithmuller 2015).  
Natural evolution of corneodesmosome morphology and distribution is, indeed, present in 
corneocytes from the most superficial SC layers, i.e. during the process of desquamation. 
Such differences, however, are not prominent between the cells collected from the deeper 
parts of the SC selected for the present study (7th strip).  
Fluhr J, Lachmann N, Baudouin C, Msika P, Darlenski R, De Belilovsky C, Bosssert J,  Colomb E, 
Burdin B, Haftek M. Development and Organization of Human Stratum Corneum After Birth. 
Electron Microscopy Isotropy Score and Immunocytochemical Corneocyte Labelling as 
Epidermal Maturation’s Markers in Infancy. Br J Dermatol 2014; 171(5): 978-86. doi: 
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We have also showed similar uniformity in murine models (Thyssen JID, 2019). 
 
The authors sampled non-lesional skin, at 2 cm distance from the lesional sites. It could well 
be that the skin at this 2 cm distance is affected by the inflammation at the lesional sites (e.g 
via diffusion of inflammatory molecules or migration of inflammatory cells). Since the non-
lesional skin sites were not investigated by tissue morphology (which is understandable 
given the pediatric population), the authors conclusions that “inflammation as such is not 
required for abrogation of the mechanical properties of the corneocytes” may therefore be 
overstated. Could it be that more distant uninvolved skin (e.g. at a different body location) 
would render a different study outcome? In line with this comment, were any local disease 
severity parameters assessed (e.g. SUM score), besides the overall SCORAD, to better define 
the non-lesional skin?   
1. 
We appreciate these comments. We restricted our studies to a consistent body region (The 
volar forearm) to avoid any regional differences. We do accept that a subclinical 
inflammation could potentially influence results. We have modified the discussion to reflect 
this. We do not have SUM scores available to analyse. 
Minor remarks: 
Methods section, “Atomic force microscopy (AFM)”: The third sentence repeats itself partly. 
Thank you, we have corrected this typo 
Methods section, “FLG genotyping”: ‘&209xA’ should be ‘Y2092X’ 
Thank you, we have now corrected this 
Competing Interests: No competing interests were disclosed.
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